Clinical Trial Update: A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on erdafitinib in participants with metastatic or locally advanced urothelial carcinoma (Phase 1/2); results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Erdafitinib (erdafitinib)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Urothelial Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-10-25